Podcasts about bioethics committee

Brains are weird. Bodies are weird. People are weird! Brains, bodies, and people together in a psychological or medical setting? Man, it can get REAL weird. Ethical conundrums abound, like navigating boundaries, bias in treatment, managing power dynamics… And that's just the tip of the iceberg! So who's in charge of figuring out the ethics behind all of this? Meet the Chief of Ethics for the American Psychological Association, Lindsay Childress-Beatty. And hear stories from the hospital from Andy Kondrat. He's the one that doctors call when they or the patients they serve are experiencing ethical medical questions..Suggested episodes: Body Integrity Dysphoria: When being disabled is a desire I downloaded my soulmate: Stories of love and AI TOPS: A woman summits Everest, a man considers a body transplant, and world-record hat-wearing Faking it: Munchausen syndrome and the compulsion to be ill GUESTS:  Andy Kondrat: Ethics consultant and Assistant Professor of Biomedical Sciences at Cedars‑Sinai Medical Center in Los Angeles, CA. He's a member of the Bioethics Committee, and co-director of CSMC's Responsible Conduct of Research training course Lindsay Childress-Beatty: Chief of Ethics for the American Psychological Association Khaleel Rahman, Jessica Severin de Martinez, Meg Fitzgerald, Robyn Doyon-Aitken, and Meg Dalton contributed to this show. Audacious with Chion Wolf is available as a podcast on Apple Podcasts, Spotify, Amazon Music, Tune In, Listen Notes, or wherever you get your podcasts. Subscribe and never miss an episode. Join the conversation on Facebook,Instagram, TikTok, and email.Support the show: https://www.wnpr.org/donateSee omnystudio.com/listener for privacy information.

Our guest for today Dr. Kanchan Anand is a doctor specializing in internal medicine and nephrology. She has been practicing her profession in Washington DC for over two decades. She chairs the Bioethics Committee. She has been awarded and recognized several times. She started as an entrepreneur in solo practice and now works with the largest health system in her area. Talking about the 60 seconds relaxation techniques, she tells us that it is based on three principles. They are; Deep Breathing, Connecting with the positivity of the Universe and Gratitude. --- Support this podcast: https://anchor.fm/tbcy/support

Dr. Clayman is a co-founder of Flexion Therapeutics and has served as our President, Chief Executive Officer and as one of our directors since our inception in 2007. Dr. Clayman also serves as the Chairman of the board of directors of both Anokion SA and Ribometrix. Previously, Dr. Clayman had a lengthy career at Eli Lilly and Company, where he was most recently Vice President, Lilly Research Laboratories, and General Manager of Chorus, Lilly’s early-phase development accelerator. During his career at Lilly, Dr. Clayman also led its Global Regulatory Affairs division, the Cardiovascular Discovery Research and Clinical Investigation, Research and Development at Advanced Cardiovascular Systems, a medical device subsidiary of Lilly, the Internal Medicine Division, the Lilly Clinic, Lilly’s dedicated Phase 1 unit, and served as Chair of Lilly’s Bioethics Committee. Prior to his tenure at Lilly, Dr. Clayman was an Assistant Professor in the School of Medicine at the University of Pennsylvania, where his research centered on the immunopathogenesis of renal disease. Dr. Clayman is the recipient of the Physician Scientist Award from the National Institutes of Health. Dr. Clayman earned a B.A., cum laude, from Yale University and an M.D. from the University of California, San Diego School of Medicine. Following an internship and residency in Internal Medicine at the University of California, San Francisco Moffitt Hospitals, Dr. Clayman completed clinical and research fellowships in Nephrology at the University of Pennsylvania.

Renowned Valley physician Zuhdi Jasser, Staff Internist to members of U.S.Congress & Supreme Court Justices at the U.S. Capitol from May of 1997 to April of 1999, and past-President of the Arizona Medical Association and Chairman of the Bioethics Committee at Good Samaritan Hospital, on concerns about the virus.See omnystudio.com/listener for privacy information.

Dr. Jeremy Fine, a native of Johannesburg, South Africa, grew up in Los Angeles. He completed his medical training in internal medicine at Cedars Sinai Medical Center in 2004 and was then selected to be Chief Resident, a role in which he enjoyed teaching the practice and more importantly, the "art" of medicine to physicians and medical students. Dr. Fine has served on the Executive Committee, Bioethics Committee and the Medical Informatics Committee at Cedars-Sinai Medical Center. He is also a former Clinical Instructor of Medicine at both the UCLA and USC Schools of Medicine. Dr. Fine is board certified in Internal Medicine. His practice philosophy incorporates an emphasis on not only listening to his patients but also hearing what they have to say. He was chosen by Los Angeles Magazine as one of the Best Doctors in Los Angeles for his exemplary skills and innovative approach to medicine. He has also been selected as one of California's Favorite Physicians. In 2010, he was voted Most Compassionate Doctor. Dr. Fine loves to travel and has practiced medicine and lectured in cities across the globe including Oslo, Norway; Sydney, Australia; Nagasaki, Japan and Tel Aviv, Israel. He and his wife, Sharon have two sons, Oliver and Caleb.

The president's voice

With Dr. Dawn Davies, Chair of the Canadian Paediatric Society's Bioethics Committee.

This week on Part II of our CRISPR series, guest correspondent Falguni Joshi continues exploring the nuances of the CRISPR patent dispute with Professor Sherkow and Steve Hollander. First, our guests explain the shift from a first-to-invent to a first-to-file system in the United States, the advantages of the change, and how the CRISPR patent dispute outcome would be different under a first-to-invent regime. Next, Professor Sherkow and Steve explore the procedural history from the interference proceeding through the Court of Appeals. Professor Sherkow explains why he thinks UC Berkeley’s chances of success on appeal are low. Our guests then turn to an interesting analogy, a foreign third party and practical considerations for UC Berkeley and the Broad Institute while the controversy is ongoing. This podcast wraps up with a conversation about the implications of the CRISPR patent dispute for the scientific and legal communities. Steven Hollander works in the area of not-for-profit and patent law and writes on the intersection of scientific innovation, bioethics, and law. He is a member of the New York City Bar Association's Bioethics Committee where he is the chair of the Patent Law Subcommittee. He received a B.A. from Washington University in St. Louis, a Certificate in Premedical Sciences from Columbia University, and a J.D., Cum Laude, from Maurice A. Dean School of Law at Hofstra University where he was an Associate Editor for the Hofstra Law Review. Professor Sherkow is an Associate Professor of Law at the New York Law School Innovation Center for Law and Technology, where he teaches a variety of courses related to intellectual property. His research focuses on how scientific developments, especially in the biosciences, affect patent law and litigation. Professor Sherkow has been a frequent commentator on patent matters in popular outlets such as the Wall Street Journal, The New York Times, the Los Angeles Times, and NPR. He also has experience as a patent litigator at Gibson, Dunn & Crutcher in New York.   Music on this week’s episode: Clocks Set by Silent Partner: https://youtu.be/Ym8r-34xu0M Experimental by strange day: https://soundcloud.com/strange-day Our theme song is Roller Blades by Otis McDonald: https://youtu.be/Ym8r-34xu0M   Subscribe to us on Apple Podcasts at https://itunes.apple.com/us/podcast/fordham-intellectual-property/id1158550285 and leave us a review! Website: www.fordhamiplj.org Twitter: @FordhamIPLJ Facebook: www.facebook.com/FordhamIPLJ Patreon: www.patreon.com/fordhamiplj

In this two part series, guest correspondent Falguni Joshi delves into the world of CRISPR-Cas9—a revolutionary gene editing technology that has made headlines recently. For this week’s episode, Falguni sits down with Dr. Raj Mandal to understand how CRISPR works, what its implications are and how Dr. Mandal uses it in his lab to conduct cancer research. Falguni then turns to the underlying patent dispute with Professor Jacob Sherkow and Steven Hollander. Professor Sherkow and Steve explain how the dispute began, the differences in the innovations made by the two parties, and the procedural history. Dr. Raj Mandal is a Head and Neck Surgery fellow at Memorial Sloan Kettering Cancer Center in New York City. In addition to clinical work, Dr. Mandal is actively involved in cancer research using gene editing technologies such as CRISPR Cas9. Steven Hollander works in the area of not-for-profit and patent law and writes on the intersection of scientific innovation, bioethics, and law. He is a member of the New York City Bar Association’s Bioethics Committee where he is the chair of the Patent Law Subcommittee. He received a B.A. from Washington University in St. Louis, a Certificate in Premedical Sciences from Columbia University, and a J.D., cum laude, from Maurice A. Dean School of Law at Hofstra University where he was an Associate Editor for the Hofstra Law Review. Professor Sherkow is an Associate Professor of Law at the New York Law School Innovation Center for Law and Technology, where he teaches a variety of courses related to intellectual property. His research focuses on how scientific developments, especially in the biosciences, affect patent law and litigation. Professor Sherkow has been a frequent commentator on patent matters in popular outlets such as the Wall Street Journal, The New York Times, the Los Angeles Times, and NPR. He also has experience as a patent litigator at Gibson, Dunn & Crutcher in New York.   Music on this week’s episode: Clocks Set by Silent Partner: https://youtu.be/Ym8r-34xu0M Experimental by strange day: https://soundcloud.com/strange-day Our theme song is Roller Blades by Otis McDonald: https://youtu.be/Ym8r-34xu0M   Subscribe to us on Apple Podcasts at https://itunes.apple.com/us/podcast/fordham-intellectual-property/id1158550285 and leave us a review! Website: www.fordhamiplj.org Twitter: @FordhamIPLJ Facebook: www.facebook.com/FordhamIPLJ Patreon: www.patreon.com/fordhamiplj

On this edition of the Jewish Sacred Aging Podcast, Rabbi Peter Kasdan, retired rabbi of Temple Emanu-El in Livingston, NJ, discusses his work with the Jewish Genetic Disease Consortium and his efforts to encourage Jewish couples to take part in pre-marital genetic screening and counseling regarding these diseases.   About Rabbi Kasdan Rabbi Peter Kasdan currently serves on the Bioethics Committee of the Sarasota Memorial Hospital, is the Rabbinic Advisor to both the Canavan Foundation and the Jewish Genetic Disease Consortium and is the current Chair of The Central Conference of American Rabbi's Taskforce on Jewish Genetic Disease. Rabbi Kasdan has received many awards in his rabbinate, but is most proud of his NFTY Life Membership Award, the Distinguished Service Award of the UAHC Fund For Reform Judaism, the CCAR's 2007 Rabbi Samuel Cook Award for Lifetime Service in Youth Work and Temple Emanu-El's 2001 Shofar Award for his life-long work in the area of Social Justice and Tikkun Olam.

Book discussion welcomes the the author of No Time to Die: Kira Peikoff. In a Washington, D.C. research lab, a brilliant scientist is attacked by his own test subjects. At Columbia University, a talented biochemist is lured out of her apartment and never seen again. In the Justice Department's new Bioethics Committee, agent Les Mahler sees a sinister pattern emerging...Zoe Kincaid is a petite college student whose rare genetic makeup may hold the key to a powerful medical breakthrough. When she is kidnapped, the very thing mankind has wanted since the dawn of time threatens to unleash our final destruction.Join me at four eastern, three central and two mountain to discuss this outatanding novel and what happens when someone is trying to develop a way to stop the aging process and cure fatal diseases. What will Zoe's fate be you have to read this book to find out. We will also talk about how she created the storyline for the novel and the characters. Join me: Fran Lewis author, educator, and editor of MJ Magazine and talk show host.

In a Washington, D.C. research lab, a brilliant scientist is attacked by his own test subjects. At Columbia University, a talented biochemist is lured out of her apartment and never seen again. In the Justice Department’s new Bioethics Committee, agent Les Mahler sees a sinister pattern emerging… Zoe Kincaid is a petite college student whose rare genetic makeup may hold the key to a powerful medical breakthrough. When she is kidnapped, the very thing mankind has wanted since the dawn of time threatens to unleash our final destruction.